Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$6.95M |
| 2 |
Apple
AAPL
|
+$6.94M |
| 3 |
COL
Rockwell Collins
COL
|
+$5.18M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$5.04M |
| 5 |
Molson Coors Class B
TAP
|
+$4.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$9.64M |
| 2 |
Acuity Brands
AYI
|
+$4.57M |
| 3 |
Mondelez International
MDLZ
|
+$3.38M |
| 4 |
Costco
COST
|
+$2.98M |
| 5 |
Intuit
INTU
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.55% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Healthcare | 13.84% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Staples | 10.1% |
Similar funds
Bayesian Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Bayesian Capital Management held 735 positions worth $419M, up 54% from $271M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bayesian Capital Management deployed $129M of net new capital in Q3 2017, opening 336 new positions and adding to 76 existing holdings. Its largest new stake was Accenture: 53,319 shares worth $7.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Vodafone, an estimated $1.72M trimmed.
- Bayesian Capital Management's largest Q3 2017 buy was Accenture: 53,319 shares worth $7.2M.
- Bayesian Capital Management added most to Rockwell Collins in Q3 2017, an estimated $5.18M increase.
- Bayesian Capital Management's biggest Q3 2017 reduction was Vodafone, cutting an estimated $1.72M.
- Bayesian Capital Management fully exited Nike in Q3 2017, selling an estimated $9.64M.
- Bayesian Capital Management's ten largest holdings make up 13% of its $419M portfolio in Q3 2017.
- Bayesian Capital Management opened 336 new positions and closed 277 in Q3 2017.
- Bayesian Capital Management's portfolio value rose 54% quarter-over-quarter to $419M.
Based on Bayesian Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.